Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Randomized Experiments01:13

Randomized Experiments

9.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.1K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

206
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
206
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

350
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
350
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

829
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
829
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

643
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
643

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Personalized Treatment Selection for Multivariate Ordinal Scale Outcomes and Multiple Treatments.

Pharmaceutical statistics·2025
Same author

Selection of the optimal personalized treatment from multiple treatments with right-censored multivariate outcome measures.

Journal of applied statistics·2024
Same author

Optimal Personalized Treatment Selection with Multivariate Outcome Measures in a Multiple Treatment Case.

Communications in statistics: Simulation and computation·2024
Same author

Prevalence and Treatment Utilization of Patients Diagnosed with Depression and Anxiety Disorders Based on Kentucky Medicaid 2012-2019 Datasets.

Journal of depression & anxiety·2023
Same author

Personalized treatment selection using observational data.

Journal of applied statistics·2023
Same author

Prevalence and Treatment for Alcohol Use Disorders Based on Kentucky Medicaid 2012-2019 Datasets.

Journal of alcoholism and drug dependence·2023

Related Experiment Video

Updated: Feb 18, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K

A probability based method for selecting the optimal personalized treatment from multiple treatments.

Chathura Siriwardhana1, Meng Zhao2, Somnath Datta3

  • 11 Department of Complementary & Integrative Medicine, John A. Burns School of Medicine, University of Hawaii, HI, USA.

Statistical Methods in Medical Research
|November 18, 2017
PubMed
Summary

This study introduces a novel method for optimal treatment assignment using patient covariates. The approach accurately identifies the best treatment, potentially improving patient outcomes and survival times.

Keywords:
Design variablespersonalized treatmentssingle index models

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Related Experiment Videos

Last Updated: Feb 18, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.9K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K

Area of Science:

  • Biostatistics
  • Medical Informatics
  • Clinical Trial Design

Background:

  • Personalized medicine requires effective treatment assignment strategies.
  • Existing methods often rely on conditional means, limiting applicability across diverse models and error structures.

Purpose of the Study:

  • To propose a novel method for optimal treatment assignment in a K-treatment scenario using individual patient covariate information.
  • To develop a metric for treatment dominance that is robust and applicable to various statistical models.

Main Methods:

  • The proposed method utilizes patient-specific scores derived from covariates to compare treatments.
  • It employs Single Index Models to link outcome variables to covariates, offering flexibility beyond conditional mean approaches.
  • The method assesses treatment dominance through surrogate quantities of conditional probabilities.

Main Results:

  • Empirical investigations demonstrate high accuracy in correct treatment assignments.
  • The method exhibits desirable large-sample properties and robustness against deviations from the Single Index Model structure.
  • Treatment selection using the proposed metric shows no loss in average reward when treatments are closely ranked.

Conclusions:

  • The proposed method provides an accurate and robust approach for optimal treatment assignment based on individual patient data.
  • Real-world data analysis indicates potential improvements in average response and survival time.
  • This strategy enhances personalized treatment decisions in clinical practice.